1 |
McKhann G., Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: a report of the NINCDS-ADRDA Work Group, Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44
DOI
|
2 |
Schaadt BK, Hendel HW, Gimsing P, Jonsson V, Pedersen H, Hesse -Aprotinin scintigraphy in amylodosis. J Nucl Med 2003;44:177-83
|
3 |
Klunk WE, Debnath ML, Pettegrew JW. Chrysamine-G binding to Alzheimer and control brain: Autopsy study of a new amyloid probe. Neurobiol Aging 1995;16:541-8
DOI
ScienceOn
|
4 |
Han H, Cho C-G, Lansbury PT Jr. Technetium complexes for the quantitation of brain amyloid. J Am Chem Soc 1996;118:4506-7
DOI
ScienceOn
|
5 |
Kung HF, Molnar M, Billings J, Blau M. Synthesis and biodistribution of neutral lipid-soluble Tc-99m complexes that cross the blood-brain barrier. J Nucl Med 1984;25:326-32
|
6 |
Dezutter NA, de Groot TJ, Busson RH, Janssen GA, Verbruggen AM. Preparation of Tc-99m- conjugates of chrysamine G, potential probes for the beta-amyloid protein of Alzheimer's disease. J Label Cmpd Radiopharm 1999;42:309-24
DOI
ScienceOn
|
7 |
Wischik CM, Harrington CR, Rickard JE, Horsley D. Neurofibrillary labels. 2002 PCT WO 02/075318 A2
|
8 |
Mathis CA, Holt DP, Wang Y, Huang GF, Debmath ML, Klunk WE. Lipophilic 11C-labelled thioflavin-T analogues for imaging amyloid plaques in Alzheimer's disease. J Label Compd Radiopharm 2001;44:S26-S8
DOI
ScienceOn
|
9 |
Marshall JR, Stimson ER, Ghilardi JR, Vinters HV, Mantyh PW, Maggio JE. Noninvasive imaging of peripherally injected Alzheimer's disease type synthetic ATEX>$\beta$ amyloid in vivo. Bioconjugate Chem 2002;13:276-84
DOI
ScienceOn
|
10 |
Ono M, Kung M-P, Hou C, Kung HF. Benzofuran derivatives as A -aggregate-specific imaging agents for Alzheimer's disease. Nucl Med Biol 2002;29:633-42
DOI
ScienceOn
|
11 |
Oya S, Plössl K, Kung M-P, Stevenson DA, Kung HF. Small and neutral TcVO BAT, bisaminoethanthiol ( ) complexes for developing new brain imaging agents. Nucl Med Biol 1998;25: 135-40
DOI
ScienceOn
|
12 |
Weiner MF. Alzheimer's disease: diagnosis and treatment. Harvard Rev. Psychiatry 1997;4:306-16
DOI
ScienceOn
|
13 |
Bornebroek M, Verzijlbergen JF, Haan J, Van Scheyen EJ, Verhoeff NPLG, Pauwels EKJ, et al. Potential for imaging cerebral amyloid deposits using -labelled serum amyloid P component and SPET. Nucl Med Commun 1996;17:929-33
DOI
ScienceOn
|
14 |
Mathis CA, Wang Y, Holt DP, Huang GF, Debnath ML, Klunk WE. Synthesis and Evaluation of 11C-Labeled 6-Substituted 2- Arylbenzothiazoles as Amyloid Imaging Agents. J Med Chem 2003;46:2740-54
DOI
ScienceOn
|
15 |
Jeong JM, Kim YJ, Lee YS, Ko JI, Son M, Lee DS, et al. Lipiodol solution of a lipophilic agent, -TDD, for the treatment of liver cancer. Nucl Med Biol 2001;28:197-204
DOI
ScienceOn
|
16 |
Zhen W, Han H, Anguiano M, Lemere CA, Cho C-G, Lansbury PT Jr. Synthesis and amyloid binding properties of rhenium complexes: preliminary progress toward a reagent for SPECT imaging of Alzheimer's disease brain. J Med Chem 1999;42:2805-15
DOI
ScienceOn
|
17 |
Selkoe DJ. Amyloid -protein and the genetics of Alzheimer's disease. J Biol Chem 1996;271:18295-8
DOI
|
18 |
Ashburn TT, Han H, McGuinness BF, Lansbury PT. Amyloid probes based on Congo Red distinguish between fibrils comprising different peptides. Chem Biol 1996;3:351-8
DOI
ScienceOn
|
19 |
Zhuang Z-P, Kung M-P, Wilson A, Lee C-W, Plössl K, Hou C, et al. Structure-activity relationship of imidazo[1,2-a]pyridines as ligands for detecting -amyloid plaques in the brain. J Med Chem 2003;46:237-43
DOI
ScienceOn
|
20 |
Saito Y, Buciak J, Yang J, Pardridge WM. Vector-mediated delivery of -labeled -amyloid peptide through the blood-brain barrier and binding to Alzheimer disease amyloid of the /vector complex. Proc Natl Acad Sci USA 1995;92:10227-31
|
21 |
Zhuang Z-P, Kung M-P, Hou C, Skovronsky D, Gur TL, Trojanowski JQ, et al. Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates. J Med Chem 2001;44:1905-14
DOI
ScienceOn
|
22 |
Dezutter NA, Dom RJ, de Groot TJ, Bromans GM, Verbruggen AM. -MAMA-chrysamine G, a probe for beta-amyloid protein of Alzheimer's disease. Eur J Nucl Med 1999;26:1392-9
DOI
|
23 |
Chang YS, Jeong JM, Lee Y-S, Kim HW, Rai BG, Kim YJ, et al. Synthesis and evaluation of benzothiophene derivatives as ligands for imaging -amyloid plaques in Alzheimer's disease. Nucl Med Biol 2006;33:811-820
DOI
ScienceOn
|
24 |
Mathis CA, Bacskai BJ, Kajdasz ST, McLellan ME, Frosch MP, Hyman BT, et al. A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. Bioorg Med Chem Lett 2002;12:295-8
DOI
ScienceOn
|
25 |
Zhuang Z-P, Kung M-P, Hou C, Plössl K, Skovronsky D, Gur TL, et al. IBOX (2-(4'-dimethylaminophenyl)-6-iodobenzoxazole): a ligand for imaging amyloid plaques in the brain. Nucl Med Biol 2001;28:887-94
DOI
ScienceOn
|
26 |
Klunk WE, Mathis CA, Wang Y. Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and vivo imaging and prevention of amyloid deposition. US Patent 2002/0133019 A1
|
27 |
Yankner BA. Mechanism of neuronaldegeneration in Alzheimer's disease. Neuron 1996;16:921-32
DOI
ScienceOn
|
28 |
Klunk WE, Debnath ML, Pettegrew JW. Development of small molecule probes for the beta-amyloid protein of Alzheimer's disease. Neurobiol Aging 1994;15:691-8
DOI
ScienceOn
|